InspireMD Inc
XBER:II2

Watchlist Manager
InspireMD Inc Logo
InspireMD Inc
XBER:II2
Watchlist
Price: 5.843 EUR -2.42% Market Closed
Market Cap: €47.2m

Wall Street
Price Targets

II2 Price Targets Summary
InspireMD Inc

Wall Street analysts forecast II2 stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for II2 is 13.78 EUR with a low forecast of 13.645 EUR and a high forecast of 14.185 EUR.

Lowest
Price Target
13.645 EUR
134% Upside
Average
Price Target
13.78 EUR
136% Upside
Highest
Price Target
14.185 EUR
143% Upside
InspireMD Inc Competitors:
Price Targets
RVTY
Revvity Inc
24% Upside
XLO
Xilio Therapeutics Inc
257% Upside

Revenue
Forecast

3% / Year
Past Growth
77% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss
3% / Year
Past Growth
77% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss

For the last 12 years the compound annual growth rate for InspireMD Inc's revenue is 3%. The projected CAGR for the next 3 years is 77%.

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-9%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-9%
Average Miss

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-91%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-91%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is II2's stock price target?
Price Target
13.78 EUR

According to Wall Street analysts, the average 1-year price target for II2 is 13.78 EUR with a low forecast of 13.645 EUR and a high forecast of 14.185 EUR.

What is InspireMD Inc's Revenue forecast?
Projected CAGR
77%

For the last 12 years the compound annual growth rate for InspireMD Inc's revenue is 3%. The projected CAGR for the next 3 years is 77%.

Back to Top